Publications

5439 Results

The Southwest Oncology Group's quality control program for human tumor cloning laboratories. , and the Southwest Oncology Group Committee for Human Tumor Cloning.

Authors
GM Clark;DD Von Hoff
Journal / Conference
4th Conference on Human Tumor Cloning (Tucson, January 8-10)
Year
1984
Research Committee(s)
Gynecologic and Leukemia
Study Number(s)
SWOG-8091, SWOG-8092

High-dose methotrexate with leucovorin rescue plus vincristine in advanced sarcoma: A Southwest Oncology Group study.

Authors
CB Vaughn;E McKelvey;SP Balcerzak;K Loh;RL Stephens;L Baker
Journal / Conference
Cancer Treat Rep 68:409-410
Year
1984
Research Committee(s)
Sarcoma
Study Number(s)
SWOG-7729

Randomized comparisons of radiotherapy and CCNU versus radiotherapy, CCNU plus Procarbazine for the treatment of malignant gliomas following surgery: A Southwest Oncology Group report.

Authors
HJ Eyre;JM Quagliana;J Frank;RM O'Bryan;B McDonald;JE Rivkin
Journal / Conference
J Neuro-Oncol 1:171-177
Year
1983
Research Committee(s)
Brain
Study Number(s)
SWOG-7404

Phase II evaluation of Anguidine in central nervous system tumors. A Southwest Oncology Group study.

Authors
JW Goodwin;RH Bottomley;CB Vaughn;J Frank;RP Pugh
Journal / Conference
Cancer Treat Rep 67:285-286
Year
1983
Research Committee(s)
Brain
Study Number(s)
SWOG-7812

Phase II study of cisplatin in recurrent astrocytomas in adults: A Southwest Oncology Group study.

Authors
DJ Stewart;RM O'Bryan;M Al-Sarraf;JJ Costanzi;N Oishi
Journal / Conference
J Neuro-Oncol 1:145-147
Year
1983
Research Committee(s)
Brain
Study Number(s)
SWOG-7980

Anguidine (Diacetoxyscerpenol) in central nervous system tumors. A Southwest Oncology Group study.

Authors
W Goodwin;R Bottomley;C Vaughn;J Frank;R Pugh
Journal / Conference
ASCO, #C-900
Year
1983
Research Committee(s)
Brain
Study Number(s)
SWOG-7812

Adjuvant therapy of breast cancer: The Southwest Oncology Group experience

Authors
WA Knight III;SE Rivkin;H Glucksberg;MA Foulkes;JJ Costanzi;RL Stephens;JW Athens;RM O'Bryan
Journal / Conference
Breast Cancer Res & Treat 3(Suppl 1):27-33
Year
1983
Research Committee(s)
Breast
Study Number(s)
SWOG-7436, SWOG-7827

Phase II evaluation of rubidazone (NSC-164011) in advanced carcinoma of the breast A Southwest Oncology Group study

Authors
FE Smith;N Gad-el-Mawla;B Tranum;LH Baker;FJ Panettiere;JW Athens;M Foulkes
Journal / Conference
Investigational New Drugs 1: 315-319
Year
1983
Research Committee(s)
Breast
Study Number(s)
SWOG-7726

Phase II evaluation of Amsacrine (m-AMSA) in solid tumors, myeloma, and lymphoma: A University of Arizona and Southwest Oncology Group study

Authors
FR Ahmann;F Meyskens Jr;SE Jones;RM Bukowski;JH Saiers;DH Ryan;J Costanzi;CB Vaughn;CA Coltman Jr
Journal / Conference
Cancer Treat Rep 67:697-700
Year
1983
Research Committee(s)
Multiple sites
Study Number(s)
SWOG-7963

Mitoxantrone in advanced breast cancer: A Phase II trial of the Southwest Oncology Group

Authors
WA Knight;DD Von Hoff;JA Neidhart;BL Tranum;C Fabian;SE Jones
Journal / Conference
Investigational New Drugs 1:181-184
Year
1983
Research Committee(s)
Breast
Study Number(s)
SWOG-8008